How to Get MOTS-c: Confirm 2,174 Da on the COA

How to get MOTS-c is a sequence, and the order is not cosmetic. Two of the nine steps below can only be completed before payment clears, and one of them can only be completed after the parcel arrives, so doing them out of order removes checks rather than delaying them.

Each step is written so that failure is observable. Nothing here describes administration, because the material is sold for laboratory research and there is no approved product behind it. What follows is a procedure for evaluating documents and handling a vial.

How to get MOTS-c: the nine steps in order

The right-hand column is the useful one. It marks the point at which each step becomes impossible to redo, which is what makes the ordering matter rather than a matter of preference.

Step 1: establish that there is no prescription to obtain

People who search where to get MOTS-c usually begin by looking for a clinical route, and the honest first step is to close that door properly rather than to work around it. A prescription needs an approved product to prescribe. MOTS-c has no marketing authorisation in the United States, European Union, or United Kingdom, so there is nothing to write.

The compounding question is separate and also closed. A 503A pharmacy may use a bulk drug substance only where there is an applicable USP monograph, the substance is a component of an approved drug, or it appears on the FDA's 503A bulks list. MOTS-c meets none of the three, and the advisory process that could eventually change that has not concluded. Anyone told otherwise is being told something the list does not support.

Steps 2 and 3: shortlist on records, then ask for the lot in stock

Shortlisting is quick because the criterion is binary. A supplier either publishes third-party analysis with a laboratory name and a report date, or it publishes a number. Everything that publishes only a number leaves the list at this point, regardless of how the storefront looks.

Step 3 is the request that separates the remainder: ask for the certificate covering the lot currently in stock, not the certificate for the product. A supplier holding batch-level documentation answers in minutes. One that does not will send a generic file, quote a purity figure, or explain why the specific document is unavailable, and each of those is an answer. This is also the moment to ask which laboratory ran the work, because a report with no laboratory and no date leads nowhere when followed. A buyer working out where to get MOTS-c peptide can complete both of these steps without spending anything, which is why they belong before the storefront comparison rather than after it.

Step 4: read the chromatogram before you read the percentage

Peptide purity is measured by reversed-phase HPLC with ultraviolet detection, usually at 214 nm, where the amide bond of the backbone absorbs strongly. Detection at 280 nm depends on aromatic side chains and reports differently. A certificate that does not state its wavelength has omitted the parameter that makes the figure comparable to anyone else's.

The reported number is area under the curve for the main peak divided by total integrated area, which makes it relative and sensitive to the analyst's choices: gradient, run length, and the threshold below which small peaks are not integrated at all. Two laboratories can analyse one vial and report meaningfully different figures without either being dishonest, which is exactly why ICH Q2(R2) treats method description as part of the result rather than an appendix to it.

What the trace shows and the number hides is the shape of the impurity fraction. For a 16-residue synthetic peptide, a shoulder eluting close to the main peak usually indicates a deletion sequence, one amino acid short, which a percentage cannot distinguish from a scatter of small unrelated peaks.

Step 5: confirm the measured mass against 2,174.6 Da

Purity says how much of the sample is one substance. Identity says which substance. Only mass spectrometry answers the second question, and it answers it by comparison: measured mass against the mass calculated from the sequence.

MOTS-c is MRWQEMGYIFYPRKLR, 16 residues, which gives an average mass of about 2,174.6 Da and a monoisotopic mass of about 2,173.1 Da. Those figures differ by roughly 1.5 Da, so a certificate printing one theoretical value without naming the convention has left out something you need. A deconvoluted electrospray measurement should sit within a few daltons of the correct target. A shift near 16 Da has an obvious candidate in this sequence, since it carries two methionines and methionine oxidises readily, and that is a conversation to have with the supplier rather than an automatic rejection.

Steps 6 and 7: mass balance, endotoxin, and the code at checkout

A 10 mg vial holds 10 mg of powder, and powder includes residual water and counterion. Karl Fischer titration reports the water. The salt form reports the rest: material purified by reversed-phase HPLC is often isolated as a trifluoroacetate salt, and MOTS-c carries three arginines, a lysine, and a free N-terminal amine, so it can hold several TFA equivalents. At three equivalents roughly 14 percent of the labelled mass is counterion. Where the work involves cell culture, the LAL endotoxin figure matters too, reported in EU/mg against a stated limit rather than implied by the word sterile.

Step 7 is arithmetic. The single MOTS-C presentation lists at $75.00 and the code PEPTIDEDECK reduces it to $37.50, which is $3.75 per milligram of labelled mass before any salt correction. Three, five, or ten vials take 3, 5, or 10 percent off the list price instead, and there is no published statement that the code and the quantity tiers combine, so treat them as alternatives. Free shipping begins at $250: one discounted vial is well short of it and roughly seven reach it. The full cost picture is broken down in our MOTS-c price analysis, and reconstitution arithmetic is covered in the peptide calculator guide.

Steps 8 and 9: match the label, then log and store

Step 8 is the only check that cannot be done in advance, and it is the one most people skip. Read the lot number printed on the vial and compare it against the lot number on the certificate you were sent. If they match, the analysis describes your material. If the vial carries no lot number, or a different one, everything read in steps 4 through 6 described something else.

Step 9 is record keeping and handling. Log the lot, the receipt date, the condition of the cake in the vial, and the certificate reference together, because a year later that record is the only thing linking the two. Lyophilised peptide is held frozen, protected from light and moisture, and allowed to reach room temperature before opening so condensation does not enter the vial. Reconstituted solutions are markedly less stable than dry powder, which is a stability property rather than a use instruction, and one we cover generally in how peptide half-life is measured.

Where the sequence still fails

Completing all nine steps establishes what is in the vial to the limit that documents allow, and that limit is real. A certificate cannot show that the sample analysed represents the lot unless sampling is described, and it says nothing about manufacture, because analysis happens after synthesis. There is also no pharmacopoeial monograph for MOTS-c, so no specification exists for a certificate to be judged compliant against.

The larger gap is the compound itself. MOTS-c was characterised by Lee and colleagues in Cell Metabolism in 2015 in cell culture and mice, and most of what followed is rodent work. The only human clinical programme was CB4211, a MOTS-c analogue rather than MOTS-c, which completed a Phase 1a/1b study of 88 participants (NCT03998514) in April 2021 before its sponsor wound down. No Phase 3 exists. Readers asking where can i get MOTS-c with better evidence behind it are asking a question the literature cannot currently answer, and the category framing sits in what research peptides actually are.